Newsroom

Industry News

2 Sep

NXT-ID Patents Methods to Add Electronics to Make a Wallet Smart

 NXT-ID, Inc. (NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that it has submitted a patent application for methods to integrate intelligent systems into a wallet to form a smart wallet.  This patent primarily discusses mechanical methods and approaches to add electronics to...

Read more

29 Aug

Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology

Intellipharmaceutics International Inc. (IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced an enhancement of its Rexista(TM) abuse-deterrence technologies with a significant improvement designed to prevent overdose when more pills than prescribed are swallowed...

Read more

28 Aug

Stevia First Now Open for Business in a Really Big Way

For anyone new, thanks for visiting our blog, and for those of you who’ve been following along, then you are in for a surprise, as we have reached an all new milestone in the growth of our Company. Put simply, we’ve accelerated our commercialization plans, and today we’re selling...

Read more

28 Aug

NXT-ID (NXTD) CNBC Ad Schedule for Wocket(TM) Smart Wallet to Resume for September Targeting New York and Los Angeles Markets

NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, announces the 30 second spots on CNBC for its next generation smart wallet, Wocket™ will resume in September, starting with targeted New York financial markets. The CNBC advertisements will air daily during prime-time morning and afternoon programs....

Read more

28 Aug

Actinium (ATNM) to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10th

Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J. Dave, President and CEO of Actinium will present at the Rodman & Renshaw Annual Global Investment Conference sponsored by H.C....

Read more

26 Aug

Stevia First (STVF) Gains Massive Sales Advantage Through Exclusive Distribution and Licensing Agreements With Qualipride

Company’s Supply Chain Capacity Now One of Largest Within Stevia Industry Stevia First Corp. (OTCQB: STVF) (“Stevia First” or the “Company”), an agricultural biotechnology company based in California’s Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the...

Read more

26 Aug

Anavex (AVXL) Selects The Alfred Hospital in Melbourne, Australia as Lead Site for Phase 2a Alzheimer’s Clinical Trial

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, has selected The Alfred Hospital in Melbourne, Australia as the lead site for its upcoming...

Read more

26 Aug

Arch Therapeutics (ARTH) Will Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014

Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2014, at The Palace Hotel in New York...

Read more

Page 215 of 227« First...102030...213214215216217...220...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address